Sumatriptan Tablet
Product Images NDC 55700-936

4 FDA label images from Quality Care Products, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 55700-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (1)

Image Description (1)
Label for Sumatriptan Tablets USP 50 mg, unit-dose tablets packaged and distributed by Quality Care Products, LLC. The label includes storage instructions, barcode, GTIN 00355700936099, and NDC 55700-936-09. Distributed by Aurobindo Pharma USA, Inc., East Windsor, NJ.*
FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan tablets at doses of 25 mg, 50 mg, and 100 mg compared to placebo. The vertical axis represents the estimated probability of response, and the horizontal axis represents time in minutes up to 240 minutes.*
FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
A line graph showing the estimated probability of headache remediation or rescue over 24 hours from the initial dose for sumatriptan at doses 25 mg, 50 mg, 100 mg, compared to placebo. The x-axis represents time in hours, and the y-axis represents the estimated probability percentage. Higher doses show increased probability over time compared to placebo.*
FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical Structure (Sumatriptan Str)
Chemical structure of Sumatriptan Succinate depicted as a 2D molecular diagram showing its key functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.